Aim
To investigate the diagnostic accuracy of O-(2-[
18
F]-fluoroethyl)-L-tyrosine (
18
F-FET) and fluoromethyl-(
18
F)-dimethyl-2-hydroxyethyl-ammonium chloride (
18
F-FCH) computed tomography (CT) in patients with primary low-grade gliomas (LGG).
Methods
The study enrolled patients with magnetic resonance imaging (MRI)-suspected LGG. Patients underwent both
18
F-FET and
18
F-FCH positron emission tomography (PET)-CT. Brain PET-CT was performed according to standard protocol – 20 minutes after intravenous injection of 185 MBq of
18
F-FET and 185 MBq of
18
F-FCH PET. Surgery and pathohistological diagnosis were performed in the next two weeks.
Results
We observed significantly better concordance between tumor histology and
18
F-FET PET (weighted Kappa 0.74) compared with both
18
F-FCH (weighted Kappa 0.15) and MRI (weighted Kappa 0.00). Tumor histology was significantly associated with
18
F-FET (odds ratio 12.87; 95% confidence interval [CI], 0.49-333.70;
P
= 0.013, logistic regression analysis). Receiver operating characteristic curve analysis comparing
18
F-FCH (area under the curve [AUC] 0.625, 95% CI 0.298-0.884) and
18
F-FET (AUC 0.833, 95% CI 0.499-0.982) showed better diagnostic properties of
18
F-FET (AUC difference 0.208, 95% CI -0.145 to 0.562,
P
= 0.248).
Conclusion
Performing PET-CT in patients with newly diagnosed LGG should be preceded by a selection of an appropriate radiopharmaceutical.
18
F-FET seems to be more accurate than
18
F-FCH in the LGG diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.